Skip to main content
Erschienen in: Current Pain and Headache Reports 12/2015

01.12.2015 | Episodic Migraine (R Cowan, Section Editor)

Are Episodic and Chronic Migraine One Disease or Two?

verfasst von: Reuben Burshtein, Aaron Burshtein, Joshua Burshtein, Noah Rosen

Erschienen in: Current Pain and Headache Reports | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Migraine is a debilitating headache disorder that has a significant impact on the world population, in both economic and sociologic capacities. Migraine has two main categories: (1) chronic migraine (CM), defined as the patient having 15 or more headache days per month, with at least five attacks fulfilling measures for EM with aura or EM without aura, and (2) episodic migraine (EM), defined as less than 15 headache days per month. With this definition, CM can only exist in the presence of EM, and it questions whether the two are separate diseases. Migraine has a significant impact on the population, as each year, about 2.5 % of patients with EM develop new-onset CM (Manack et al., Curr Pain Headache Rep 15:70–78, 2011) (Loder et al. Headache 55:214–228, 2015), with certain risk factors being evident only with CM. In addition, there are comorbid diseases that are only associated with CM, suggesting two separate diseases rather than one. Differentiation in response to treatments, both preventive and abortive, demonstrates both a similarity and a difference in EM versus CM. Also, comparing the two processes based upon functional imaging has been a recent development, beginning to show a physiological difference in regional cortical thickness, cortical surface area, and regional volumes in patients with EM and CM. Evidence regarding whether EM and CM demonstrate one disease with a significant level of complication or if two independent processes is inconclusive, and additional research must be performed to further characterize their relationship.
Literatur
1.••
Zurück zum Zitat Katsarava Z, Lipton R, et al. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16:86–92. The study provides an in-depth look at the differences between EM and CM and the reasoning behind defining them as separate conditions for management and classification. PubMedCentralCrossRefPubMed Katsarava Z, Lipton R, et al. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16:86–92. The study provides an in-depth look at the differences between EM and CM and the reasoning behind defining them as separate conditions for management and classification. PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Merikangas K. Contributions of epidemiology to our understanding of migraine. Headache. 2013;53:230–46.CrossRefPubMed Merikangas K. Contributions of epidemiology to our understanding of migraine. Headache. 2013;53:230–46.CrossRefPubMed
3.••
Zurück zum Zitat Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders; 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. The study provides the standard for classifying headaches. It is still in beta version and requires further testing and refinement but the basis for all research and clinical descriptions in the field. CrossRef Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders; 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. The study provides the standard for classifying headaches. It is still in beta version and requires further testing and refinement but the basis for all research and clinical descriptions in the field. CrossRef
4.
Zurück zum Zitat Reed M, Lipton R, et al. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results. Headache. 2015;55:76–87.CrossRefPubMed Reed M, Lipton R, et al. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results. Headache. 2015;55:76–87.CrossRefPubMed
5.
Zurück zum Zitat Ruscheweyh R, Straube A, et al. Correlation of headache frequency and psychosocial impairment in migraine: a cross-sectional study. Headache. 2014;54:861–71.CrossRefPubMed Ruscheweyh R, Straube A, et al. Correlation of headache frequency and psychosocial impairment in migraine: a cross-sectional study. Headache. 2014;54:861–71.CrossRefPubMed
6.•
Zurück zum Zitat Lipton R, Buse D, et al. Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2014;54:830–49. This is an interesting paper attempting to approach the classification of migraine subtypes in a more scientific rational as opposed to a consensus model. CrossRefPubMed Lipton R, Buse D, et al. Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2014;54:830–49. This is an interesting paper attempting to approach the classification of migraine subtypes in a more scientific rational as opposed to a consensus model. CrossRefPubMed
7.
Zurück zum Zitat Manack A, Buse D, Lipton R. Chronic migraine: epidemiology and disease burden. Curr Pain Headache Rep. 2011;15:70–8.CrossRefPubMed Manack A, Buse D, Lipton R. Chronic migraine: epidemiology and disease burden. Curr Pain Headache Rep. 2011;15:70–8.CrossRefPubMed
9.
Zurück zum Zitat Loder S, Loder E, et al. The prevalence, burden, and treatment of severe, frequent, and migraine headaches in US minority populations: statistics from National Survey Studies. Headache. 2015;55:214–28.CrossRefPubMed Loder S, Loder E, et al. The prevalence, burden, and treatment of severe, frequent, and migraine headaches in US minority populations: statistics from National Survey Studies. Headache. 2015;55:214–28.CrossRefPubMed
10.
Zurück zum Zitat Cho S-J, Chu MK. Risk factors of chronic daily headache or chronic migraine. Curr Pain Headache Rep. 2015;19:465. Cho S-J, Chu MK. Risk factors of chronic daily headache or chronic migraine. Curr Pain Headache Rep. 2015;19:465.
12.
Zurück zum Zitat Bigal M, Sheftell F, et al. Assessment of migraine disability using the Migraine Disability Assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache. 2003;43:336–42. Bigal M, Sheftell F, et al. Assessment of migraine disability using the Migraine Disability Assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache. 2003;43:336–42.
13.•
Zurück zum Zitat Buse D, Lipton R, et al. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81:428–32. This is a key article derived from American Migraine Prevention and Prevalence study data demonstrating the comorbidity difference between EM and CM types. CrossRefPubMed Buse D, Lipton R, et al. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81:428–32. This is a key article derived from American Migraine Prevention and Prevalence study data demonstrating the comorbidity difference between EM and CM types. CrossRefPubMed
14.
Zurück zum Zitat Hamelsky S, Lipton R. Epidemiology of migraine. Curr Pain Headache Rep. 2001;5:189–94. Hamelsky S, Lipton R. Epidemiology of migraine. Curr Pain Headache Rep. 2001;5:189–94.
15.
Zurück zum Zitat Bigal M, Lipton R, et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48:1157–68.CrossRefPubMed Bigal M, Lipton R, et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48:1157–68.CrossRefPubMed
16.
Zurück zum Zitat Bigal M, Goadsby P, et al. Obesity, migraine, and chronic migraine. Neurology. 2007;68:1851–61.CrossRefPubMed Bigal M, Goadsby P, et al. Obesity, migraine, and chronic migraine. Neurology. 2007;68:1851–61.CrossRefPubMed
17.
Zurück zum Zitat Peterlin B, Zonderman A, et al. Episodic migraine and obesity and the influence of age, race, and sex. Neurology. 2013;81:1314–21. Peterlin B, Zonderman A, et al. Episodic migraine and obesity and the influence of age, race, and sex. Neurology. 2013;81:1314–21.
18.
Zurück zum Zitat Lipton R, Chu M. Conceptualizing the relationship between chronic migraine and episodic migraine. Expert Rev Neurother 2009;1451 + . Lipton R, Chu M. Conceptualizing the relationship between chronic migraine and episodic migraine. Expert Rev Neurother 2009;1451 + .
19.
Zurück zum Zitat Lipton R, Stewart W, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–9. Lipton R, Stewart W, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–9.
20.
Zurück zum Zitat Diener H, Brin M, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30:804–3. Diener H, Brin M, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30:804–3.
21.
Zurück zum Zitat Aurora S, Brin M, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010;30:793–803.CrossRefPubMed Aurora S, Brin M, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010;30:793–803.CrossRefPubMed
22.
Zurück zum Zitat Burstein R, Bajwa Z, et al. An association between migraine and cutaneous allodynia. Ann Neurol. 2000;47:614–24.CrossRefPubMed Burstein R, Bajwa Z, et al. An association between migraine and cutaneous allodynia. Ann Neurol. 2000;47:614–24.CrossRefPubMed
23.•
Zurück zum Zitat Schwedt T, Li J, et al. Accurate classification of chronic migraine via brain magnetic resonance imaging. Headache. 2015;55:762–77. This is a fascinating article denoting imaging differences between episodic and chronic migraine types. This is the best evidence supporting structural differences between these conditions. CrossRefPubMed Schwedt T, Li J, et al. Accurate classification of chronic migraine via brain magnetic resonance imaging. Headache. 2015;55:762–77. This is a fascinating article denoting imaging differences between episodic and chronic migraine types. This is the best evidence supporting structural differences between these conditions. CrossRefPubMed
Metadaten
Titel
Are Episodic and Chronic Migraine One Disease or Two?
verfasst von
Reuben Burshtein
Aaron Burshtein
Joshua Burshtein
Noah Rosen
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports / Ausgabe 12/2015
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-015-0529-5

Beutel versus Maschine: Beste Beatmungstechnik bei Herzstillstand gesucht

02.05.2024 Kardiopulmonale Reanimation Nachrichten

Stehen die Chancen auf eine Rückkehr der Spontanzirkulation nach Herz-Kreislauf-Stillstand bei manueller oder maschineller Beatmung besser? Und unterscheidet sich das neurologische Outcome nach der Reanimation? Das belgische Herzstillstand-Register liefert die Daten für einen direkten Vergleich zwischen Beutel und Beatmungsgerät.

Tipps für den Umgang mit Behandlungsfehlern

01.05.2024 DGIM 2024 Kongressbericht

Es ist nur eine Frage der Zeit, bis es zu einem Zwischenfall kommt und ein Behandlungsfehler passiert. Doch wenn Ärztinnen und Ärzte gut vorbereitet sind, schaffen es alle Beteiligten den Umständen entsprechend gut durch diese Krise. 

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.